Login to Your Account

Clinic Roundup

Friday, November 4, 2011

• Auxilium Pharmaceuticals Inc., of Malvern, Pa., reported that clinical practice data from the TRiUS (Testim Registry in the United States) study showed that daily administration of Testim 1 percent (testosterone gel) resulted in significantly improved sexual function and increased total testosterone levels in men with hypogonadism.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription